Clinical evaluation of erythropoietin (EPO) in oncology.
Oster
W
W
Research Laboratories of Behringwerke AG, Marburg, Germany.
Schindel
F
F
Heinrichs
H
H
D004921:Erythropoietin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000188:drug therapy*; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin